GREGORY L WEAVER Insider Trading $ELOX Eloxx Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY L WEAVER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY L WEAVER. GREGORY L WEAVER is Chief Financial Officer in Marina Biotech, Inc. ($MRNA) and Director in Celsion CORP ($CLSN) and in Eloxx Pharmaceuticals, Inc. ($ELOX) and Chief Financial Officer in Eloxx Pharmaceuticals, Inc. ($SVON) and Director in ATOSSA GENETICS INC ($ATOS) and Director in Egalet Corp ($EGLT).
GREGORY L WEAVER in Eloxx Pharmaceuticals, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of GREGORY L WEAVER:
Holdings: 11,517 shares
Current Value: $2,649
Latest Transaction: Mar 16 2020
$ELOX Market Capitalization: $4.75M
$ELOX Previous Close: $0.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GREGORY L WEAVER in Eloxx Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRX, ATOS, CLSN, ELOX, EGLT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Option Exercise | M | 0.00 | 3,750 | 0 | 0 | ||
| Mar 16 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Payment of Exercise | F | 2.85 | 1,086 | 3,095 | 10,431 | 11.5 K to 10.4 K (-9.43 %) | |
| Mar 16 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Buy | M | 0.00 | 3,750 | 0 | 11,517 | 7.8 K to 11.5 K (+48.28 %) | |
| Jan 31 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | CHIEF FINANCIAL OFF ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| Jan 31 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | CHIEF FINANCIAL OFF ... | Payment of Exercise | F | 3.91 | 1,733 | 6,776 | 7,767 | 9.5 K to 7.8 K (-18.24 %) |
| Jan 31 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | CHIEF FINANCIAL OFF ... | Buy | M | 0.00 | 5,000 | 0 | 9,500 | 4.5 K to 9.5 K (+111.11 %) |
| Jan 31 2019 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Jan 31 2019 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | CHIEF FINANCIAL OFF ... | Option Exercise | A | 11.53 | 60,000 | 691,800 | 60,000 | |
| Mar 26 2018 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Chief Financial Off ... | Buy | P | 8.56 | 4,500 | 38,520 | 4,500 | 0 to 4.5 K |
| Dec 22 2017 | SVON | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Chief Financial Off ... | Option Exercise | A | 7.00 | 399,266 | 2,794,862 | 399,266 |
Page: 1